Hara Megumi, Fukuoka Mami, Tashiro Katsuya, Ozaki Iwata, Ohfuji Satoko, Okada Kenji, Nakano Takashi, Fukushima Wakaba, Hirota Yoshio
Department of Preventive Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan.
Department of Infection Control, Saga-ken Medical Centre Koseikan, 400 Nakahara, Kase, Saga City, Saga, 840-8571, Japan.
BMC Infect Dis. 2015 Feb 6;15:45. doi: 10.1186/s12879-015-0777-3.
Recent studies worldwide have reported increasing numbers of adults diagnosed with Bordetella pertussis despite receiving childhood vaccinations. This study describes a pertussis outbreak at a university medical faculty campus and examines the effectiveness of diphtheria, tetanus, and pertussis (DTaP) vaccination completed during infancy in Japan.
After the outbreak, self-administered questionnaires and serum samples were collected from students on campus to determine the incidence of pertussis and underlying diseases. Pertussis was diagnosed on the basis of clinical criteria and serum anti-pertussis toxin antibody levels. Using data collected from 248 first and second grade students who had submitted copies of their vaccination records, we evaluated the effectiveness of DTaP vaccination in infancy against adult pertussis.
Questionnaire responses were obtained from 636 students (of 671 registered students; 95% response rate). Of 245 students who reported a continuous cough during the outbreak period, 84 (attack rate: 13.2%) were considered "probable" pertussis cases that met clinical criteria. The outbreak occurred mainly in first and second grade students in the Faculty of Medicine. Of 248 students who provided vaccination records, 225 had received 4 DTaP doses (coverage: 90.7%); the relative risk of the complete vaccination series compared to those with fewer than 4 doses or no doses for probable cases was 0.48 (95% confidence interval: 0.24-0.97).
Waning protection was suspected due to over time. Booster vaccination for teenagers and development of highly efficacious pertussis vaccines are needed.
世界各地最近的研究报告称,尽管接受了儿童期疫苗接种,但被诊断出感染百日咳博德特氏菌的成年人数量仍在增加。本研究描述了一所大学医学院校园内的百日咳疫情,并调查了日本婴儿期完成的白喉、破伤风和百日咳(DTaP)疫苗接种的有效性。
疫情爆发后,从校园内的学生中收集了自行填写的问卷和血清样本,以确定百日咳的发病率和潜在疾病。根据临床标准和血清抗百日咳毒素抗体水平诊断百日咳。利用从248名提交了疫苗接种记录副本的一、二年级学生收集的数据,我们评估了婴儿期DTaP疫苗接种对成人百日咳的有效性。
共收到636名学生(登记学生671名;回复率95%)的问卷回复。在245名报告在疫情期间持续咳嗽的学生中,84名(发病率:13.2%)被认为是符合临床标准的“可能”百日咳病例。疫情主要发生在医学院的一、二年级学生中。在提供疫苗接种记录的248名学生中,225名接受了4剂DTaP疫苗(接种率:90.7%);与接种剂量少于4剂或未接种疫苗的可能病例相比,完成全程疫苗接种系列的相对风险为0.48(95%置信区间:0.24-0.97)。
随着时间的推移,怀疑保护作用在减弱。需要为青少年接种加强疫苗,并研发高效的百日咳疫苗。